Table 2: Statistical analysis results of serum levels of cytokines and LL-37 in patients with psoriasis and healthy controls.

  Patients ()
Median (IQR), mean
Healthy controls ()
Median (IQR), mean

IL-1RA (pg/mL)2.26 (0.00–7.18), 4.400.00 (0.00–1.62), 1.470.020*
IL-2 (pg/mL)0.81 (0.59–1.25), 1.050.00 (0.00–0.92), 0.840.007*
IL-12 (pg/mL)2.71 (0.00–4.80), 3.230.00 (0.00–1.36), 1.330.071
IL-17A (pg/mL)0.31 (0.00–1.37), 1.590.00 (0.00–2.75), 1.520.936
IL-22 (pg/mL)0.11 (0.09–0.18), 0.150.10 (0.10–0.13), 0.110.625
IL-23 (pg/mL)1.57 (1.44–2.00), 1.990.95 (0.45–1.24), 1.02<0.001*
IFN-γ (pg/mL)2.94 (2.46–5.18), 4.530.50 (0.00–2.06), 1.34<0.001*
LL-37 (ng/mL)11.78 (9.75–16.90), 13.468.73 (7.73–11.60), 9.430.011*

IL: interleukin; IL-1RA: IL-1 receptor antagonist; IFN: interferon; IQR: interquartile range.
aMann-Whitney U test between healthy controls and patients with psoriasis.
*denotes statistically significant difference at .